Mealey's (November 16, 2018, 9:09 AM EST) -- WASHINGTON, D.C. — A Native American tribe and a drug company are taking their fight to use the tribe’s sovereign immunity to shield it from inter partes review (IPR) of patents...
Tribe, Drugmaker Heading To Supreme Court After Bids For Rehearing, Stay Denied
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login